- Report
- October 2024
- 185 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- September 2024
- 100 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2023
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- December 2023
- 100 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
- Report
- December 2023
- 180 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,160GBP
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
Poland
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
India
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
Germany
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
France
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2023
- 80 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2025
- 75 Pages
Global
From €3500EUR$4,119USD£3,077GBP

Lumefantrine is an antimalarial drug used to treat and prevent malaria. It is a combination of two active ingredients, lumefantrine and artemether, and is available in both oral and injectable forms. Lumefantrine is used in combination with other antimalarial drugs to treat uncomplicated Plasmodium falciparum malaria, a type of malaria caused by a parasite. It is also used to prevent malaria in people who are at risk of contracting the disease. Lumefantrine is effective against both chloroquine-resistant and multi-drug resistant strains of malaria.
Lumefantrine is a key component of many antimalarial drug combinations, and is widely used in the treatment of infectious diseases. It is available in many countries, and is often used in combination with other antimalarial drugs to treat malaria.
Companies in the Lumefantrine market include Novartis, Sanofi, GlaxoSmithKline, Cipla, and Ranbaxy. Show Less Read more